The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 5,387 | 1,455,904 | SH | SOLE | 1,455,904 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 7,055 | 1,356,813 | SH | SOLE | 1,356,813 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 19,515 | 1,599,592 | SH | SOLE | 1,599,592 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 41,386 | 1,018,362 | SH | SOLE | 1,018,362 | 0 | 0 | ||
INVUITY INC | COM | 46187J205 | 4,213 | 1,080,272 | SH | SOLE | 1,080,272 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,679 | 329,942 | SH | SOLE | 329,942 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 22,185 | 1,074,316 | SH | SOLE | 1,074,316 | 0 | 0 | ||
OBALON THERAPEUTICS INC | COM | 67424L100 | 5,275 | 2,453,338 | SH | SOLE | 2,453,338 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 89,907 | 2,021,738 | SH | SOLE | 2,021,738 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 76 | 8,293 | SH | SOLE | 8,293 | 0 | 0 | ||
RESTORATION ROBOTICS INC | COM | 76133C103 | 11,645 | 3,355,786 | SH | SOLE | 3,355,786 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 27,427 | 1,030,689 | SH | SOLE | 1,030,689 | 0 | 0 |